Evaluation of Key Molecular Markers in Adult Diffuse Gliomas Based on a Novel Combination of Diffusion and Perfusion MRI and MR Spectroscopy
Journal of Magnetic Resonance Imaging · 2024
DOI: 10.1002/jmri.28793 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2024. Verfasst von Xiaorui Su und 10 weiteren Autor:innen. Beteiligte Einrichtung: Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital of Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Department of Science and Technology of Sichuan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Preoperative identification of isocitrate dehydrogenase (IDH) mutation and 1p/19q codeletion status could help clinicians select the optimal therapy in patients with diffuse glioma. Although, the value of multimodal intersection was underutilized.
Purpose
To evaluate the value of quantitative MRI biomarkers for the identification of IDH mutation and 1p/19q codeletion in adult patients with diffuse glioma. Study Type Retrospective. Population Two hundred sixteen adult diffuse gliomas with known genetic test results, divided into training (N = 130), test (N = 43), and validation (N = 43) groups. Sequence/Field Strength Diffusion/perfusion‐weighted‐imaging sequences and multivoxel MR spectroscopy (MRS), all 3.0 T using three different scanners. Assessment The apparent diffusion coefficient (ADC) and cerebral blood volume (CBV) of the core tumor were calculated to identify IDH‐mutant and 1p/19q‐codeleted statuses and to determine cut‐off values. ADC models were built based on the 30th percentile and lower, CBV models were built based on the 75th centile and higher (both in five centile steps). The optimal tumor region was defined and the metabolite concentrations of MRS voxels that overlapped with the ADC/CBV optimal region were calculated and added to the best‐performing diagnostic models. Statistical Tests DeLong's test, diagnostic test, and decision curve analysis were performed. A P value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital of Sichuan University, Chengdu, China.
- Huaxi Glioma Center, West China Hospital of Sichuan University, Chengdu, China.
- Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, China.
- Department of Radiology, West China Hospital of Sichuan University, Chengdu, China.
- Department of Neurosurgery, West China Hospital of Sichuan University, Chengdu, China.
- Department of Pathology, West China Hospital of Sichuan University, Chengdu, China.
ORCID-Profile: Huaiqiang Sun, Qiyong Gong, Qiang Yue
Förderung
- China Postdoctoral Science Foundation
- Department of Science and Technology of Sichuan Province
- National Natural Science Foundation of China
- Science and Technology Department of Sichuan Province
Zitieren
APA
Su, X., Yang, X., Sun, H., Liu, Y., Chen, N., Li, S., Huang, Z., Shao, H., Zhang, S., Gong, Q., & Yue, Q. (2024). Evaluation of Key Molecular Markers in Adult Diffuse Gliomas Based on a Novel Combination of Diffusion and Perfusion MRI and MR Spectroscopy. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.28793
Vancouver
Su X, Yang X, Sun H, Liu Y, Chen N, Li S, et al. Evaluation of Key Molecular Markers in Adult Diffuse Gliomas Based on a Novel Combination of Diffusion and Perfusion MRI and MR Spectroscopy. Journal of Magnetic Resonance Imaging. 2024. doi:10.1002/jmri.28793
BibTeX
@article{Su2024,
author = {Su, Xiaorui and Yang, Xibiao and Sun, Huaiqiang and Liu, Yanhui and Chen, Ni and Li, Shuang and Huang, Zongyao and Shao, Hanbing and Zhang, Simin and Gong, Qiyong and Yue, Qiang},
title = {Evaluation of Key Molecular Markers in Adult Diffuse Gliomas Based on a Novel Combination of Diffusion and Perfusion MRI and MR Spectroscopy},
journal = {Journal of Magnetic Resonance Imaging},
year = {2024},
doi = {10.1002/jmri.28793}
}
EUVIMED